Skip to main content
. 2017 Apr 10;9(4):32. doi: 10.3390/cancers9040032

Figure 2.

Figure 2

Targeting both VEGF induction of angiogenesis and androgen synthesis or AR signaling inhibits two critical signaling pathways in prostate cancer (PC) progression. Note that hypoxia induced VEGF can also be suppressed by targeting HIF1α with HIF1 inhibitors (not shown).